Yasser Heakal, Ph.D.

2009 Pennsylvania State University, State College, PA, United States 
"Yasser Heakal"
Mean distance: 17811


Sign in to add mentor
Mark Kester grad student 2009 Penn State
 (Identification of novel pharmacological approaches to inhibit neurotensin receptor -1 mitogenic signaling in breast cancer cells.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Heakal Y, Kester M, Savage S. (2011) Vemurafenib (PLX4032): an orally available inhibitor of mutated BRAF for the treatment of metastatic melanoma. The Annals of Pharmacotherapy. 45: 1399-405
Jiang Y, DiVittore NA, Kaiser JM, et al. (2011) Combinatorial therapies improve the therapeutic efficacy of nanoliposomal ceramide for pancreatic cancer. Cancer Biology & Therapy. 12: 574-85
Heakal Y, Woll MP, Fox T, et al. (2011) Neurotensin receptor-1 inducible palmitoylation is required for efficient receptor-mediated mitogenic-signaling within structured membrane microdomains. Cancer Biology & Therapy. 12: 427-35
Heakal Y, Kester M. (2009) Nanoliposomal short-chain ceramide inhibits agonist-dependent translocation of neurotensin receptor 1 to structured membrane microdomains in breast cancer cells. Molecular Cancer Research : McR. 7: 724-34
Kester M, Heakal Y, Fox T, et al. (2008) Calcium phosphate nanocomposite particles for in vitro imaging and encapsulated chemotherapeutic drug delivery to cancer cells. Nano Letters. 8: 4116-21
Zolnik BS, Stern ST, Kaiser JM, et al. (2008) Rapid distribution of liposomal short-chain ceramide in vitro and in vivo. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 36: 1709-15
See more...